APGE
APGE
NASDAQ · Biotechnology

Apogee Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$78.53
+5.53 (+7.58%)
As of Mar 25, 9:55 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 19 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target +29.3% upside
Low Target $78.76
Average Target $101.57
High Target $153.22
Current Price $78.53
Current
$78.53
Target
$101.57
$78.76 $101.57 avg $153.22
Scenario Analysis
Bear Case
$78.76
0.3%
Low target
Base Case
$101.57
+29.3%
Avg target
Bull Case
$153.22
+95.1%
High target
Risk/Reward
324.7x
Highly favorable
Price in Context
52-Week High
$84.56
-7.1% from high
52-Week Low
$26.20
+199.7% from low
50-Day SMA
$73.88
+6.3% vs SMA
200-Day SMA
$52.13
+50.6% vs SMA
RSI (14)
48.1
Neutral
Target vs 52W High
$101.57
+20.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%